Директор по бухгалтерскому учету Dolby Laboratories продал акции на $83,6 тыс., а штатные пенсионные фонды увеличили свои позиции

Dolby Laboratories (NYSE:DLB – Get Free Report) CAO Ryan Nicholson sold 1,348 shares of the stock in a transaction that occurred on Monday, August 10th. The shares were sold at an average price of $62.04, for a total value of $83,629.92. Following the completion of the sale, the chief accounting officer directly owned 35,636 shares of the company’s stock, valued at $2,210,857.44. This represents a 3.64% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Ryan Nicholson also recently made the following trade(s): - On Tuesday, August 4th, Ryan Nicholson sold 357 shares of Dolby Laboratories stock. The stock was sold at an average price of $60.63, for a total transaction of $21,644.91. Dolby Laboratories Price Performance NYSE:DLB opened at $62.34 on Friday. The stock has a market cap of $5.84 billion, a P/E ratio of 26.53 and a beta of 0.80. The company has a fifty day moving average price of $53.35 and a 200 day moving average price of $58.45. Dolby Laboratories has a one year low of $48.26 and a one year high of $75.66. Dolby Laboratories Announces Dividend The company also recently announced a quarterly dividend, which will be paid on Wednesday, August 19th. Stockholders of record on Tuesday, August 11th will be issued a $0.36 dividend. The ex-dividend date of this dividend is Tuesday, August 11th. This represents a $1.44 annualized dividend and a dividend yield of 2.3%. Dolby Laboratories’s dividend payout ratio is presently 61.28%. Dolby Laboratories announced that its Board of Directors has authorized a stock buyback program on Thursday, July 30th that permits the company to buyback $350.00 million in outstanding shares. This buyback authorization permits the electronics maker to purchase up to 7% of its shares through open market purchases. Shares buyback programs are usually a sign that the company’s management believes its shares are undervalued. Institutional Trading of Dolby Laboratories A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Boothbay Fund Management LLC lifted its position in Dolby Laboratories by 4.1% during the 2nd quarter. Boothbay Fund Management LLC now owns 4,020 shares of the electronics maker’s stock valued at $299,000 after purchasing an additional 157 shares during the period. Covestor Ltd grew its position in shares of Dolby Laboratories by 6.0% during the 4th quarter. Covestor Ltd now owns 3,088 shares of the electronics maker’s stock worth $198,000 after buying an additional 175 shares during the period. Fifth Third Bancorp grew its position in shares of Dolby Laboratories by 34.7% during the 4th quarter. Fifth Third Bancorp now owns 746 shares of the electronics maker’s stock worth $48,000 after buying an additional 192 shares during the period. State of Michigan Retirement System raised its stake in shares of Dolby Laboratories by 1.4% during the first quarter. State of Michigan Retirement System now owns 14,700 shares of the electronics maker’s stock worth $883,000 after buying an additional 200 shares during the last quarter. Finally, Raymond James Financial Inc. raised its stake in shares of Dolby Laboratories by 1.0% during the second quarter. Raymond James Financial Inc. now owns 24,344 shares of the electronics maker’s stock worth $1,808,000 after buying an additional 235 shares during the last quarter. 58.56% of the stock is currently owned by institutional investors and hedge funds. Wall Street Analysts Forecast Growth A number of brokerages have commented on DLB. Barrington Research reissued an “outperform” rating and set a $90.00 price objective on shares of Dolby Laboratories in a report on Monday, June 15th. Wall Street Zen lowered shares of Dolby Laboratories from a “buy” rating to a “hold” rating in a research report on Saturday, August 1st. Rosenblatt Securities reissued a “buy” rating and set a $85.00 price target on shares of Dolby Laboratories in a research note on Friday, July 31st. Finally, Weiss Ratings reissued a “hold (c-)” rating on shares of Dolby Laboratories in a report on Wednesday, June 24th. Three investment analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $90.75. Read Our Latest Research Report on Dolby Laboratories Dolby Laboratories Company Profile Dolby Laboratories, Inc is a global leader in audio and imaging technologies, specializing in the development, licensing and deployment of solutions that enhance entertainment and communications experiences. The company’s core business revolves around creating advanced audio codecs, noise reduction systems and spatial sound technologies for a wide range of applications, including cinema, broadcast, gaming, streaming and personal devices. Dolby’s licensing model enables consumer electronics manufacturers, content creators and service providers to integrate its technologies into products such as televisions, smartphones, home theater systems and set-top boxes. Among its flagship innovations are Dolby Atmos, an immersive audio format that delivers three-dimensional soundscapes for theaters and home systems; Dolby Digital and Dolby Digital Plus, widely adopted audio compression formats for broadcast and streaming; and Dolby Vision, a high-dynamic-range imaging technology that expands color, contrast and brightness in displays. Featured Articles Receive News & Ratings for Dolby Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dolby Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.